Current research indicates that HOTAIR is a negative prognostic factor for survival of patients with breast and colon cancer and glioma, and increased HOTAIR expression in patients has been correlated with increased metastasis [11, 14–16]. This evidence concerns the gene HOTAIR and colonic neoplasm.